The choice between a testosterone gel and an injection is more than a preference about needles. It involves the exact product, your diagnosis, practical handling and the risks that matter in your circumstances.
This comparison does not pick a winner or provide dose conversions. Your prescriber and pharmacist should explain the proposed formulation and train you on its use.
Compare the product you would actually receive, including handling requirements and the follow-up plan.
A topical product affects the household routine
Testosterone gels can transfer to another person through contact with the application area. Product labeling contains specific instructions intended to reduce exposure, particularly to children and women. Ask the pharmacist to review the exact directions rather than rely on a general demonstration.
Consider your normal routine, close contact with others, and your ability to follow the instructions reliably. The label for one gel concentration is not a universal instruction sheet for every cream or compounded preparation.
References: DailyMed: testosterone gel 1.62% labeling / Urology Care Foundation: low testosterone
An injection needs its own instruction
For an injectable prescription, ask who provides training, what supplies are required, how sharps are handled, and how the medicine should be stored. The route and presentation need to be explicit. Do not copy another patient’s schedule or assume that the amount in a vial is the amount to administer.
The broader TRT handbook explains why formulation follows diagnosis. This page cannot assess whether you can self-administer safely or convert between products. Those questions belong to the prescribing and dispensing professionals.
References: Endocrine Society: diagnosis and treatment guideline / FDA: BeSafeRx pharmacy checks
Approved and compounded are different categories
A compounded testosterone product is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. An approved gel’s clinical data cannot simply be assigned to a different compounded cream or injection.
Ask why that product is being selected, which pharmacy supplies it, and what evidence and instructions apply to it. The clinic shortlist uses the same product questions for every service, including paid partners.
References: FDA: compounding questions and answers / DailyMed: testosterone gel 1.62% labeling
Both routes need a complete care plan
Convenience is one factor, but safety monitoring and response assessment remain important. Ask your clinician what findings would prompt reconsidering the formulation or the treatment itself. The monitoring file covers selected issues including blood pressure, blood counts and fertility.
Use the cost file to compare the full arrangement, including training, supplies, visits and labs. A lower medication price can be a poor guide when the products and included care are different.
References: Endocrine Society: diagnosis and treatment guideline / FDA: testosterone labeling changes / Defy Medical: TRT cost estimate
Source record
- DailyMed: testosterone gel 1.62% labeling
Product-specific label. Does not establish safety or equivalence of every compounded formulation.
- Urology Care Foundation: low testosterone
Patient education on evaluation, monitoring and fertility. Current FDA update takes precedence for labeling changes.
- Endocrine Society: diagnosis and treatment guideline
Clinical guidance for men with hypogonadism; not a self-diagnosis tool.
- FDA: BeSafeRx pharmacy checks
Official resources for checking online pharmacies.
- FDA: compounding questions and answers
Compounded drugs are not FDA-approved.
- FDA: testosterone labeling changes
February 2025 update; cardiovascular boxed-warning language and blood-pressure warnings must be distinguished.
- Defy Medical: TRT cost estimate
Illustrative average, not a monthly subscription price or individual guarantee.
